Podcasts about shira johnson

Host: Shira Johnson, MD Guest: Arun Swaminath, MD Recent studies have shown that smoking cannabis can improve some of the debilitating symptoms of inflammatory bowel disease, but the overall results are still inconclusive. Based on our current understanding, what is the impact of medical cannabis on IBD? Shira Johnson and Dr. Arun Swaminath, a practicing gastroenterologist at Northwell Health and Director of the Inflammatory Bowel Diseases Program at Lenox Hill Hospital, discuss the research of using cannabis to treat IBD.

Host: Shira Johnson, MD Guest: Arun Swaminath, MD Recent studies have shown that smoking cannabis can improve some of the debilitating symptoms of inflammatory bowel disease, but the overall results are still inconclusive. Based on our current understanding, what is the impact of medical cannabis on IBD? Shira Johnson and Dr. Arun Swaminath, a practicing gastroenterologist at Northwell Health and Director of the Inflammatory Bowel Diseases Program at Lenox Hill Hospital, discuss the research of using cannabis to treat IBD.

Hear two experts talk about the link between a baby's tongue and breastfeeding. What are some signs of a tongue tie and what does that procedure even look like? Shira Johnson, IBCLC, and Dr. Katie Swanson, Certified Pediatric Dentist, give us some insight into breastfeeding a newborn. After this podcast aired, Shira wanted us to clarify some things that were mentioned: “A tongue release procedure, frenectomy, can be done well by any type of provider (dentist, ENT, physician, midwife, etc), as long as they have good experience and training. Likewise, good releases can be done with a laser, scissors, or scalpel — it is the skill of the provider that matters most, not the tool used. An experienced release provider does not use general anesthesia for babies - they either use topical anesthetic, or nothing at all. Avoid providers who say they use general for babies, as that is neither safe nor necessary. A good way to find a provider is to ask an experienced IBCLC who they recommend, or ask a potential provider how often they do frenectomies, how many they’ve done, what their training is, etc. Having it done by a less experienced provider often results in an incomplete release, which may have to be redone to provide full benefits”. Shira also wanted to note that she did not train with Dr. Ghaheri, but did get to shadow and learn from him during her education."

Host: Shira Johnson, MD Guest: David H. Clements, M.D. What do technology, mindfulness, and genetic testing have in common? These three seemingly unrelated things are all being used to treat addiction. Dr. David Clements, psychiatrist and owner of Southeastern Executive Health in Philadelphia, Pennsylvania, reveals how integrating alternative therapies, such as biofeedback and genetic testing, into his practice has enabled many patients to engage in their own therapy. Dr. Clements joins Dr. Shira Johnson to share his decision-making process and therapeutic approaches to empower patients and end the stigma of isolation.

Host: Shira Johnson, MD Guest: Bryan J. Smith, MD Are you a physician whose passion is practicing medicine? Or are you a jet-setter looking for international intrigue? As it turns out, you can be both! Once hospitalist Dr. Bryan Smith discovered Global Medical Staffing, he packed his bags and boarded a flight bound for New Zealand. A year and a half later, he chronicles his experiences abroad with Dr. Shira Johnson. In riveting detail, Dr. Smith sheds light on the benefits and challenges of foreign cultural paradigms in medicine.

Host: Shira Johnson, MD Guest: William Lemaire, MD Dr. Shira Johnson welcomes Dr. William LeMaire, author of Cross-Cultural Doctoring: On and Off the Beaten Path, who chronicles his transformation from a faculty member at the University of Miami to an international, jet-setting Ob/Gyn with the help of Global Medical Staffing. He depicts healthcare challenges many countries face today, including the continued need for medical basics.

Host: Shira Johnson, MD Guest: Thomas O'Mara, MD Transitioning to a full-time locum tenens position may sound daunting when you’re in the middle of your career and run a private practice. But through CompHeatlh pulmonologist, Dr. Thomas O'Mara, found working as a locum tenens for the past 12 years has provided him and his family with flexible scheduling and opportunities to create a better work-life balance. Dr. Shira Johnson speaks with Dr. O'Mara about his personal journey as a locum tenens that began with uncertainty and led to happiness.

Host: Shira Johnson, MD Guest: Laura Hoffman Guest: Matt Reid If you’re planning on participating in the Quality Payment Program in 2019, you may be wondering what you can—and should—be doing now to prepare for upgrading your electronic health records, or how this update could affect your computers and networks. If so, you’re not alone. To help guide you through this process, Dr. Shira Johnson is joined by two AMA staff—Senior Health IT Consultant Matt Reid and Assistant Director of Federal Affairs Laura Hoffman—who answer these and other FAQs.

Host: Shira Johnson, MD Guest: Laura Hoffman Guest: Matt Reid If you're planning on participating in the Quality Payment Program in 2019, you may be wondering what you can—and should—be doing now to prepare for upgrading your electronic health records, or how this update could affect your computers and networks. If so, you're not alone. To help guide you through this process, Dr. Shira Johnson is joined by two AMA staff—Senior Health IT Consultant Matt Reid and Assistant Director of Federal Affairs Laura Hoffman—who answer these and other FAQs.

Host: Shira Johnson, MD Guest: Laura Hoffman Guest: Matt Reid If you’re planning on participating in the Quality Payment Program in 2019, you may be wondering what you can—and should—be doing now to prepare for upgrading your electronic health records, or how this update could affect your computers and networks. If so, you’re not alone. To help guide you through this process, Dr. Shira Johnson is joined by two AMA staff—Senior Health IT Consultant Matt Reid and Assistant Director of Federal Affairs Laura Hoffman—who answer these and other FAQs.

Host: Shira Johnson, MD Guest: Laura Hoffman Guest: Matt Reid If you’re planning on participating in the Quality Payment Program in 2019, you may be wondering what you can—and should—be doing now to prepare for upgrading your electronic health records, or how this update could affect your computers and networks. If so, you’re not alone. To help guide you through this process, Dr. Shira Johnson is joined by two AMA staff—Senior Health IT Consultant Matt Reid and Assistant Director of Federal Affairs Laura Hoffman—who answer these and other FAQs.

Host: Shira Johnson, MD Guest: Bennett Omalu, MD Chronic Traumatic Encephalopathy (CTE) is a degenerative brain disease found in athletes, military veterans, and others who experience repetitive brain trauma. Pathologist Dr. Bennett Omalu coined the term "CTE" and published the first evidence for this condition after autopsying American football players. Host Dr. Shira Johnson welcomes Dr. Omalu to share the story of his discovery and the medical, athletic, and public responses that followed.

Host: Shira Johnson, MD Guest: Bennett Omalu, MD Chronic Traumatic Encephalopathy (CTE) is a degenerative brain disease found in athletes, military veterans, and others who experience repetitive brain trauma. Pathologist Dr. Bennett Omalu coined the term "CTE" and published the first evidence for this condition after autopsying American football players. Host Dr. Shira Johnson welcomes Dr. Omalu to share the story of his discovery and the medical, athletic, and public responses that followed.

Host: Shira Johnson, MD Guest: Bennett Omalu, MD Chronic Traumatic Encephalopathy (CTE) is a degenerative brain disease found in athletes, military veterans, and others who experience repetitive brain trauma. Pathologist Dr. Bennett Omalu coined the term "CTE" and published the first evidence for this condition after autopsying American football players. Host Dr. Shira Johnson welcomes Dr. Omalu to share the story of his discovery and the medical, athletic, and public responses that followed.

Host: Shira Johnson, MD Guest: Bennett Omalu, MD Chronic Traumatic Encephalopathy (CTE) is a degenerative brain disease found in athletes, military veterans, and others who experience repetitive brain trauma. Pathologist Dr. Bennett Omalu coined the term "CTE" and published the first evidence for this condition after autopsying American football players. Host Dr. Shira Johnson welcomes Dr. Omalu to share the story of his discovery and the medical, athletic, and public responses that followed.

Host: Shira Johnson, MD Guest: Ronald DeMatteo, MD, FACS A Gastrointestinal Stromal Tumor (GIST) is a rare sarcoma that begins in the digestive tract or stomach, with an incident rate in the United States of approximately 4,000 to 6,000 cases per year. Since these tumors behave differently from other gastrointestinal cancers, they require a specialized treatment plan. Host Dr. Shira Johnson chats with Ronald DeMatteo, MD, FACS, Chair of the Department of Surgery and a surgical oncologist at Penn Medicine. They discuss the diagnosis, treatment and current clinical research of GIST. Dr. DeMatteo is a world-renowned surgical expert and researcher for the rare GIST. His research breakthroughs helped develop the new standard of care for GIST.

Host: Shira Johnson, MD Guest: Ronald DeMatteo, MD, FACS A Gastrointestinal Stromal Tumor (GIST) is a rare sarcoma that begins in the digestive tract or stomach, with an incident rate in the United States of approximately 4,000 to 6,000 cases per year. Since these tumors behave differently from other gastrointestinal cancers, they require a specialized treatment plan. Host Dr. Shira Johnson chats with Ronald DeMatteo, MD, FACS, Chair of the Department of Surgery and a surgical oncologist at Penn Medicine. They discuss the diagnosis, treatment and current clinical research of GIST. Dr. DeMatteo is a world-renowned surgical expert and researcher for the rare GIST. His research breakthroughs helped develop the new standard of care for GIST.

Host: Shira Johnson, MD Guest: Ronald DeMatteo, MD, FACS A Gastrointestinal Stromal Tumor (GIST) is a rare sarcoma that begins in the digestive tract or stomach, with an incident rate in the United States of approximately 4,000 to 6,000 cases per year. Since these tumors behave differently from other gastrointestinal cancers, they require a specialized treatment plan. Host Dr. Shira Johnson chats with Ronald DeMatteo, MD, FACS, Chair of the Department of Surgery and a surgical oncologist at Penn Medicine. They discuss the diagnosis, treatment and current clinical research of GIST. Dr. DeMatteo is a world-renowned surgical expert and researcher for the rare GIST. His research breakthroughs helped develop the new standard of care for GIST.

Host: Shira Johnson, MD Guest: Ronald DeMatteo, MD, FACS A Gastrointestinal Stromal Tumor (GIST) is a rare sarcoma that begins in the digestive tract or stomach, with an incident rate in the United States of approximately 4,000 to 6,000 cases per year. Since these tumors behave differently from other gastrointestinal cancers, they require a specialized treatment plan. Host Dr. Shira Johnson chats with Ronald DeMatteo, MD, FACS, Chair of the Department of Surgery and a surgical oncologist at Penn Medicine. They discuss the diagnosis, treatment and current clinical research of GIST. Dr. DeMatteo is a world-renowned surgical expert and researcher for the rare GIST. His research breakthroughs helped develop the new standard of care for GIST.

Host: Shira Johnson, MD Physicians spend their entire careers striving to heal sick patients. But when these care providers become patients themselves, the abrupt reversal of roles can make for difficult adjustments. Host Dr. Shira Johnson sits down with Dr. John Mulligan, VP for Emergency Room Physicians Medical Group and a practicing emergency physician, to share his experience, takeaways, and advice for transitioning from doctor to patient.

Host: Shira Johnson, MD Guest: Robert Vonderheide, MD For years, the foundations of cancer treatment, surgery, chemotherapy, and radiation therapy were utilized with the objective of weakening cancer. But over the past several years, immunotherapy – therapies that enlist and strengthen the power of a patient’s immune system to attack tumors - has emerged as a new tool for fighting cancer. In August 2017, one such treatment approach, called Chimeric Antigen Receptor or CAR T-cell Therapy, received FDA approval for the treatment of children and young adults with acute lymphoblastic leukemia (ALL). Additionally, research is continuing to look at CAR-T therapy’s effectiveness for treating solid tumors as well. Host Dr. Shira Johnson sits down with Dr. Robert Vonderheide, Director of the Abramson Cancer Center of the University of Pennsylvania and the John H. Glick, MD, Abramson Cancer Center Director’s Professor, to talk about the potential of CAR-T therapy alongside other emerging immunotherapies in fighting cancer.

Host: Shira Johnson, MD Guest: Robert Vonderheide, MD For years, the foundations of cancer treatment, surgery, chemotherapy, and radiation therapy were utilized with the objective of weakening cancer. But over the past several years, immunotherapy – therapies that enlist and strengthen the power of a patient’s immune system to attack tumors - has emerged as a new tool for fighting cancer. In August 2017, one such treatment approach, called Chimeric Antigen Receptor or CAR T-cell Therapy, received FDA approval for the treatment of children and young adults with acute lymphoblastic leukemia (ALL). Additionally, research is continuing to look at CAR-T therapy’s effectiveness for treating solid tumors as well. Host Dr. Shira Johnson sits down with Dr. Robert Vonderheide, Director of the Abramson Cancer Center of the University of Pennsylvania and the John H. Glick, MD, Abramson Cancer Center Director’s Professor, to talk about the potential of CAR-T therapy alongside other emerging immunotherapies in fighting cancer.

Host: Shira Johnson, MD Guest: Robert Vonderheide, MD For years, the foundations of cancer treatment, surgery, chemotherapy, and radiation therapy were utilized with the objective of weakening cancer. But over the past several years, immunotherapy – therapies that enlist and strengthen the power of a patient’s immune system to attack tumors - has emerged as a new tool for fighting cancer. In August 2017, one such treatment approach, called Chimeric Antigen Receptor or CAR T-cell Therapy, received FDA approval for the treatment of children and young adults with acute lymphoblastic leukemia (ALL). Additionally, research is continuing to look at CAR-T therapy’s effectiveness for treating solid tumors as well. Host Dr. Shira Johnson sits down with Dr. Robert Vonderheide, Director of the Abramson Cancer Center of the University of Pennsylvania and the John H. Glick, MD, Abramson Cancer Center Director’s Professor, to talk about the potential of CAR-T therapy alongside other emerging immunotherapies in fighting cancer.

Host: Shira Johnson, MD Guest: Robert Vonderheide, MD For years, the foundations of cancer treatment, surgery, chemotherapy, and radiation therapy were utilized with the objective of weakening cancer. But over the past several years, immunotherapy – therapies that enlist and strengthen the power of a patient’s immune system to attack tumors - has emerged as a new tool for fighting cancer. In August 2017, one such treatment approach, called Chimeric Antigen Receptor or CAR T-cell Therapy, received FDA approval for the treatment of children and young adults with acute lymphoblastic leukemia (ALL). Additionally, research is continuing to look at CAR-T therapy’s effectiveness for treating solid tumors as well. Host Dr. Shira Johnson sits down with Dr. Robert Vonderheide, Director of the Abramson Cancer Center of the University of Pennsylvania and the John H. Glick, MD, Abramson Cancer Center Director’s Professor, to talk about the potential of CAR-T therapy alongside other emerging immunotherapies in fighting cancer.

Host: Shira Johnson, MD Guest: Robert Vonderheide, MD For years, the foundations of cancer treatment, surgery, chemotherapy, and radiation therapy were utilized with the objective of weakening cancer. But over the past several years, immunotherapy – therapies that enlist and strengthen the power of a patient’s immune system to attack tumors - has emerged as a new tool for fighting cancer. In August 2017, one such treatment approach, called Chimeric Antigen Receptor or CAR T-cell Therapy, received FDA approval for the treatment of children and young adults with acute lymphoblastic leukemia (ALL). Additionally, research is continuing to look at CAR-T therapy’s effectiveness for treating solid tumors as well. Host Dr. Shira Johnson sits down with Dr. Robert Vonderheide, Director of the Abramson Cancer Center of the University of Pennsylvania and the John H. Glick, MD, Abramson Cancer Center Director’s Professor, to talk about the potential of CAR-T therapy alongside other emerging immunotherapies in fighting cancer.

Host: Shira Johnson, MD Guest: Robert Vonderheide, MD For years, the foundations of cancer treatment, surgery, chemotherapy, and radiation therapy were utilized with the objective of weakening cancer. But over the past several years, immunotherapy – therapies that enlist and strengthen the power of a patient’s immune system to attack tumors - has emerged as a new tool for fighting cancer. In August 2017, one such treatment approach, called Chimeric Antigen Receptor or CAR T-cell Therapy, received FDA approval for the treatment of children and young adults with acute lymphoblastic leukemia (ALL). Additionally, research is continuing to look at CAR-T therapy’s effectiveness for treating solid tumors as well. Host Dr. Shira Johnson sits down with Dr. Robert Vonderheide, Director of the Abramson Cancer Center of the University of Pennsylvania and the John H. Glick, MD, Abramson Cancer Center Director’s Professor, to talk about the potential of CAR-T therapy alongside other emerging immunotherapies in fighting cancer.

Guest: Brendan Carr, MD Host: Shira Johnson, MD Time is critical in a medical crisis, but according to new research, the nearest facility may not always be the best place for the patient. Dr. Brendan Carr, lead author of the study and assistant professor of emergency medicine and epidemiology at the University of Pennsylvania, discusses his research with host Dr. Shira Johnson. They also look at future technology that could tell doctors and paramedics the best place to take a patient using GPS and the same system used for trauma victims.

Guest: Shan Liu, MD Host: Shira Johnson, MD Patients that come into an emergency room sometimes have to wait hours even days before they are moved to a hospital floor. A new study says more than a quarter of patients who are "boarded" in the ER after being admitted to the hospital often suffer undesirable events like missing necessary treatments or medications. Dr. Shan Liu, an attending physician at Massachusetts General Hospital in Boston and an instructor at Harvard Medical School, joins Dr. Shira Johnson to discuss her study on this growing worldwide issue.

Guest: Gloria Kuhn, MD Host: Shira Johnson, MD When should ER doctors become concerned about burnout? Many physicians show signs of career fatigue but continue to practice year after year. Dr. Gloria Kuhn, vice chair for academic affairs for the department of emergency medicine at Wayne State University, discusses her latest research with host Dr. Shira Johnson. Dr. Kuhn surveyed ER doctors to see what causes physicians to become unhappy in their jobs and the warning signs ER doctors and other physicians should look for to combat burnout.

Guest: Angela Gardner, MD Host: Shira Johnson, MD The practice of emergency room diversion began back in the late 1980s to help prevent overcrowding in busy hospitals. But does it still work? Hospitals across the country are so crowded today that ambulances are turned away regularly. Dr. Angela Gardner, president-elect of the American College of Emergency Physicians and assistant professor of emergency medicine at the University of Texas at Galveston, explores the issue of overcrowding and the policies designed to combat the problem, with host Dr. Shira Johnson.

Guest: Angela Gardner, MD Host: Shira Johnson, MD Emergency medical care makes up only three percent of the 1.5 trillion dollars the nation spends on healthcare. There are currently two bills before Congress that propose an increase in dollars spent on emergeny medical services. Host Dr. Shira Johnson is joined by Dr. Angela Gardner, president-elect of the American College of Emergency Physicians, to discuss how this legislation will improve the care in the nation's crowded emergency rooms, what part of the population will be impacted most by this legislation, and how the Obama plan will affect practicing physicians.

Guest: Alex Rosenau, MD Host: Shira Johnson, MD Doctors and nurses in the emergency department work under constant stress. So, what happens when a case is so stressful and horrific that it affects medical personnel emotionally? Dr. Alex Rosenau, vice chair of the department of emergency medicine at Lehigh Valley Hospital and Health Network in Lehigh, Pennsylvania, joins host Dr. Shira Johnson to discuss techniques and counseling services to help ED staff deal with unusually brutal cases.

Guest: Ralph Sacco, MD Host: Shira Johnson, MD Over 700,000 Americans have a new or recurrent stroke each year. Dr Ralph Sacco, professor and chairman of neurology at the University of Miami's Miller School of Medicine, discusses the leading research on treatment in the 'golden hour' after a stroke occurs. He reviews why thrombolytics have led the way after a dry infarct, but why your patients may need additional care only available in a comprehensive stroke center. As chief of neurology at Jackson Memorial Hospital in Miami and a leading researcher, Dr. Sacco joins host Dr Shira Johnson to talk about the state of the art in care after a CVA.

Guest: Marianne Gaushe-Hill, MD Host: Shira Johnson, MD When should your emergency medical services unit be transporting instead of treating? Dr. Marianne Gauche-Hill, professor of medicine at the David Geffen School of Medicine at UCLA and director of EMS at Harbor-UCLA Medical Center, reveals recent studies in the literature showing that less treatment may be more efficacious. Join Dr. Shira Johnson as she interviews Dr. Gauche-Hill to discuss scenerios when the diagnosis in the field may have a better outcome if ACLS care is delivered at the receiving facility.

Guest: Art Kellerman, MD Host: Shira Johnson, MD The emergency department is at the interface between the community and the healthcare system. What impacts the emergency department impacts us all. Dr. Art Kellerman, professor of emergency medicine at Emory University, discusses the challenges facing American healthcare and the groundwork for changing the practice of emergency medicine. As associate dean for health policy at Emory, he is on the forefront of such issues as access to care and healthcare reform. Dr. Shira Johnson is the host.

Guest: Art Kellerman, MD Host: Shira Johnson, MD In a chaotic and uncontrolled environment, the emergency department is taking the lead in clinical research. Dr. Art Kellerman, professor of emergency medicine at Emory University, discusses how clinical trials performed in this challenging environment are shaping the future of the ED and of medicine. Dr. Shira Johnson hosts as Dr. Kellerman discusses his experiences at Grady Memorial Hospital, Atlanta's only public hospital and Level 1 trauma center, as one of the nation's leading emergency care researchers.

Guest: Peter DeBlieux, MD Host: Shira Johnson, MD Who will benefit most from early intervention and treatment from the 750,000 patients hospitalized with sepsis each year? Dr Peter De Blieux, Pulmonary and Critical Care specialist from the Louisiana State University Health and Science Center, discusses early management and diagnosis including the importance of goal directed therapy. Dr Shira Johnson is the host as Dr De Blieux reviews common mistakes in sepsis management and provides case studies for learning.

Guest: Peter DeBlieux, MD Host: Shira Johnson, MD Sepsis kills 210,000 patients each year. Dr. Peter DeBlieux, professor of medicine at Louisiana State University Health Science Center and director of emergency medicine services at the Medical Center of Louisiana, discusses the latest clinical practice guidelines. He is interviewed by Dr. Shira Johnson about how to improve sepsis mortality with new therapies. Learn why early and agressive management is the key .

Guest: Benjamin Abella, MD Host: Shira Johnson, MD There are over 400,000 cardiac arrests per year. Dr Benjamin Abella assistant professor in both the department of emergency medicine and the department of medicine from the University of Pennsylvania School of Medicine discusses why 10-20% are surviving till discharge and beyond. A leading researcher in the area of resuscitation science, Dr. Abella discusses the changing epidemiology of cardiac arrest, and the science behind the improved survival. Host is Dr. Shira Johnson.

Host: Shira Johnson, MD Guest: Benjamin Abella, MD Cardiac arrest management used to mean CPR and efforts that were often futile. Now more patients are surviving until discharge because of new techniques maximizing compressions and administering hypothermia. Join host Dr. Shira Johnson with Dr. Benjamin Abella, assistant professor in the department of emergency medicine at the University of Pennsylvania, to discuss the techniques on the forefront of resuscitation medicine that are having a positive effect on patient outcomes.

Guest: Scott E. Rudkin, MD, MBA Host: Shira Johnson, MD Do you understand the financial impact of the on-call crisis and how it affects the emergency department? Dr. Scott Rudkin, associate professor of emergency medicine in the department of emergency medicine at the University of California, Irvine School of Medicine explains his research findings about the on-call crisis as well as solutions explored in California and across the nation. Learn why ambulance diversion may soon end while a fee for on-call service may be implemented. Dr. Shira Johnson hosts.

Guest: Scott E. Rudkin, MD, MBA Host: Shira Johnson, MD Who will be there to take call in your emergency department? Dr Scott Rudkin associate professor of emergency medicine at the University of California, Irvine School of Medicine, is interviewed by Dr. Shira Johnson to discuss the on-call crises which may be impacting your emergency department. Dr. Rudkin discusses the instrumental causes which include low financial reimbursement, an increased risk of litigation in trauma cases, and a desire for a better lifestyle, all of which have taken their toll on emergency department call schedules.

Guest: Trevor Duke, MD Host: Shira Johnson, MD A simple medical device such as an oxygen saturation monitor can make all the difference in a developing country. Dr. Trevor Duke, an intensive care specialist at Royal Children's Hospital in Melbourne, Australia, talks about his study which reduced the death rate from pneumonia in New Guinea by measuring oxygen saturation and administrating oxygen through a concentrator. He and host Dr Shira Johnson discuss this study and his work with the World Health Organization.

Guest: Trevor Duke, MD Host: Shira Johnson, MD In 2000 the UN developed the Millennium Developmental Goals and the fourth goal is to reduce child mortality by 2015. Dr. Trevor Duke is head of the Centre for International Child Health in Australia and collaborates with the World Health Organization to meet this goal. He is interviewed by Dr. Shira Johnson to discuss the mammoth task of reducing pediatric mortality world wide and the initial steps taken by countries involved in this effort.

Guest: Rita K. Cydulka, MD, MS Host: Shira Johnson, MD Diagnosing and treating high and low blood glucose levels is not always straightforward. Dr. Rita Cydulka, professor and vice-chair of the department of emergency medicine at Case Western Reserve University, discusses case management issues, including unusual presentations of abnormal blood sugars. In her interview with host Dr. Shira Johnson, Dr. Cydulka highlights the initial approach as well as clinical caveats for discharge and follow-up.

Guest: Christopher B. Colwell, MD Host: Shira Johnson, MD Evidence-based medicine has changed resuscitation in the field and in the emergency department. Dr. Christopher Colwell, associate director of emergency medicine at Denver Health Medical Center and medical director of the Denver Paramedic Division and the Denver Fire Department, reviews what what we know now about pre-hospital care. He discusses CPR, medications, and therapeutic post-arrest hypothermia with host Dr. Shira Johnson.

Host: Shira Johnson, MD Guest: Calvin A. Brown III, MD Once the sole domain of anesthesiologists, rapid sequence intubation is now a skill practiced by all emergency department physicians. Dr. Calvin Brown III, attending physician in the emergency department at Brigham and Woman's Hospital in Boston, explains the state of the art in intubation. Dr. Brown is interviewed by Dr. Shira Johnson as he reviews the basic technique of RSI, some of the pearls and pitfalls, and what is on the horizon for this skilled intubation technique.

Guest: Rachel Chin, MD Host: Shira Johnson, MD Tattoos and body piercings have been around for hundreds of years. But now they are turning up in your office or your ED. Dr. Rachel Chin is a professor of emergency medicine at the University of California San Francisco School of Medicine. She and Dr. Shira Johnson look at the potential complications you may see and how to treat them.

Guest: John McConnell, PhD Host: Shira Johnson, MD The reality of the Emergency Medical Treatment and Active Labor Act is that patients can not be turned away. But the economics of providing emergency care to all is overburdening hospital resources. Our guest, healthcare economist specializing in ED care and associate professor of emergency medicine at Oregon Health and Science University, Dr. John McConnell, joins host Dr. Shira Johnson to talk about the economics of emergency care. Learn strategies and solutions that could solve the on-call crisis in hospitals.

Guest: John McConnell, PhD Host: Shira Johnson, MD The concept of the surgicalist was born of economic and practical necessity. Dr. John McConnell is a health economist and an assistant professor of emergency medicine at Oregon Health and Science University whose research has focused on emergency and trauma care as well as health policy. He is interviewed by Dr. Shira Johnson to discuss how and why the role of the surgicalist evolved. Tune in to find out who may be seeing your next surgical consult from the ED. It may not be the surgeon on call.